0

Palomid 529

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP914913885
CAS914913-88-5
Structure
Molecular Weight406.43
Description≥98% (HPLC)
SolubilityDMSO: 10 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Bromodomain-Containing Protein 4 (BRD4) Inhibition Sensitizes Palomid 529-Induced Anti-Renal Cell Carcinoma Cell Activity in Vitro and in Vivo

Zhao-Yu Xing, Yin Wang, Long Cheng, Jie Chen, Xiao-Zhou He, Wei Xing

Cell Physiol Biochem. 2018;50(2):640-653.

PMID: 30308518

1

Dual mTORC1 and mTORC2 Inhibitor Palomid 529 Penetrates the Blood-Brain Barrier Without Restriction by ABCB1 and ABCG2

Fan Lin, Levi Buil, David Sherris, Jos H Beijnen, Olaf van Tellingen

Int J Cancer. 2013 Sep 1;133(5):1222-33.

PMID: 23436212

1

High-performance Liquid Chromatography Analysis of a Novel Small-Molecule, Anti-Cancer Drug, Palomid 529, in Human and Mouse Plasma and in Mouse Tissue Homogenates

Fan Lin, David Sherris, Jos H Beijnen, Olaf Van Tellingen

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 15;879(32):3823-31.

PMID: 22100549

1

RES-529: A PI3K/AKT/mTOR Pathway Inhibitor That Dissociates the mTORC1 and mTORC2 Complexes

Mark A Weinberg

Anticancer Drugs. 2016 Jul;27(6):475-87.

PMID: 26918392

1

Subconjunctival Palomid 529 in the Treatment of Neovascular Age-Related Macular Degeneration

Monica Dalal, Naima Jacobs-El, Benjamin Nicholson, Jingsheng Tuo, Emily Chew, Chi-Chao Chan, Robert Nussenblatt, Frederick Ferris, Catherine Meyerle

Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2705-9.

PMID: 23689994

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode